LICENSE AGREEMENT by and between Zogenix, Inc. and Endo Ventures Bermuda Limited dated as of May 16, 2014License Agreement • August 6th, 2014 • Zogenix, Inc. • Pharmaceutical preparations • New York
This License Agreement (this “Agreement”), effective as of the Closing (“Effective Date”), is entered into by and between Zogenix, Inc., a Delaware corporation (“Zogenix”), and Endo Ventures Bermuda Limited, a Bermuda company (“Endo”).
Asset Purchase AgreementAsset Purchase Agreement • August 6th, 2014 • Zogenix, Inc. • Pharmaceutical preparations • New York
This Asset Purchase Agreement (this “Agreement”) is made and entered into as of April 23, 2014, by and among Zogenix, Inc., a Delaware corporation (“Seller”), Endo Ventures Bermuda Limited, a Bermuda limited company (“Buyer 1”) and Endo Ventures Limited, a company organized under the laws of Ireland (“Buyer 2” and together with Buyer 1, each a “Buyer” and, collectively “Buyers”).
CERTAIN MATERIAL (INDICATED BY AN ASTERISK) HAS BEEN OMITTED FROM THIS DOCUMENT PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. MANUFACTURING AND SUPPLY...Manufacturing and Supply Agreement • August 6th, 2014 • Zogenix, Inc. • Pharmaceutical preparations • New York
This Manufacturing and Supply Agreement (together with all exhibits attached hereto, the “Agreement”), effective as of May 16, 2014 (the “Effective Date”), is by and between Zogenix, Inc., a Delaware corporation, with its principal place of business at 12400 High Bluff Drive, Suite 650, San Diego, CA 92130 (“Zogenix”) and Endo Ventures Limited, a company organized under the Laws of Ireland, with its principal place of business at No. 33 Fitzwilliam Square, Dublin 2, Ireland (“Endo”).
